These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5494284)

  • 21. [The effect of long-term hormonal contraception].
    Brehm H
    Med Welt; 1968 Sep; 38():2054-6. PubMed ID: 5712901
    [No Abstract]   [Full Text] [Related]  

  • 22. [New generation of oral contraceptives and the cardiovascular effects].
    Ben-Arie A; Hagay Z
    Harefuah; 1997 Aug; 133(3-4):111-5. PubMed ID: 9332078
    [No Abstract]   [Full Text] [Related]  

  • 23. [Should the use of oral contraceptives be stopped by the age of 40?].
    Halttunen M
    Duodecim; 2002; 118(16):1629-30. PubMed ID: 12271939
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phlebitis and thrombosis induced by contraceptive pills].
    Merklen FP; Cottenot
    Bull Acad Natl Med; 1967 Oct; 151(23):473-8. PubMed ID: 4936683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of changes in activity of some hemocoagulation factors during contraception and therapy with combinations of synthetic steroids with varied gestagenic components].
    Misinger I; Hermanská Z
    Cas Lek Cesk; 1971 Feb; 110(9):196-9. PubMed ID: 5547223
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenylmercuric acetate and some hemostatic activities of rat platelets.
    Kostka B
    Pol J Pharmacol Pharm; 1983; 35(1):37-43. PubMed ID: 6889185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood coagulation during treatment with oral contraceptives].
    Bailo U; Finzi C
    Minerva Ginecol; 1968 Dec; 20(23):1879-84. PubMed ID: 5734792
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thrombelastography in anovulatory therapy with estroprogestogens].
    Torre GC; Rosso-Chioso M; Chisalé E; Gargiulo T; Pallotti A; Sciandra F; Piras A
    Riv Ital Ginecol; 1980; 59(2-3):197-211. PubMed ID: 7256100
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
    Basdevant A; Guy-Grand B
    Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
    Gordon EM; Ratnoff OD; Jones PK
    J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of mechanism of blood coagulation and factors concerned with it in buffalo calves.
    Adaval SC; Gangwar PC
    Indian J Physiol Pharmacol; 1970 Jul; 14(3):208. PubMed ID: 5535707
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of oestro-progestogenic oral contraceptives on blood coagulation, fibrinolysis, and platelet aggregation.
    Ghezzo F; Mele A; Pegoraro L
    Haematologica; 1980 Dec; 65(6):737-45. PubMed ID: 6790364
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of an antifertility preparation on a fibrinogen-fibrinolysin system in vitro.
    Moses HA; Frazier HM; Field RM
    J Natl Med Assoc; 1969 Sep; 61(5):404-7. PubMed ID: 4242111
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of various doses of gamma-aminobutyric acid, adrenaline and insulin on coagulation time, prothrombin time and the prothromboplastic activity of rat blood].
    Karagezian KG; Saakian SS
    Ukr Biokhim Zh; 1967; 39(4):424-9. PubMed ID: 5603095
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of oral melengestrol acetate (MGA) on the pregnant heifer and on her resultant offspring.
    Schul GA; Smith LW; Goyings LS; Zimbelman RG
    J Anim Sci; 1970 Mar; 30(3):433-7. PubMed ID: 5436454
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of oral contraceptives on factor VIII levels.
    Crowell EB; Clatanoff DV; Kiekhofer W
    J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340
    [No Abstract]   [Full Text] [Related]  

  • 39. Plumbago zeylanica action on blood coagulation profile with and without blood volume reduction.
    Vijayakumar R; Senthilvelan M; Ravindran R; Devi RS
    Vascul Pharmacol; 2006 Aug; 45(2):86-90. PubMed ID: 16531123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of caffeine on free fatty acids and blood coagulation parameters of dogs.
    Bellet S; Feinberg LJ; Sandberg H; Hirabayashi M
    J Pharmacol Exp Ther; 1968 Feb; 159(2):250-4. PubMed ID: 5638645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.